Cervical intraepithelial neoplasia
Cervical Intraepithelial Neoplasia (CIN)
Cervical Intraepithelial Neoplasia (CIN) is a precancerous condition in which abnormal cell growth occurs on the surface of the cervix. CIN is classified based on the extent of cell abnormality and is an important indicator for the risk of developing cervical cancer. It is categorized into low-grade and high-grade lesions, reflecting the severity of the cellular atypia and architectural changes without evidence of stromal invasion.

Classification
CIN is classified into three grades, according to the degree of epithelial abnormality:
- CIN 1: Low-grade dysplasia, indicating mild abnormalities.
- CIN 2: Moderate dysplasia, considered high-grade but with lower risk than CIN 3.
- CIN 3: Severe dysplasia to carcinoma in situ, the highest precancerous stage.
Causes and Risk Factors
CIN is most commonly caused by persistent infection with high-risk types of Human Papillomavirus (HPV). Other risk factors include:
- Early sexual activity
- Multiple sexual partners
- Smoking
- Immunosuppression
Symptoms
CIN itself often presents no symptoms and is usually detected through routine cervical screening tests. If left untreated and progresses to cervical cancer, symptoms may include abnormal vaginal bleeding, pelvic pain, and pain during intercourse.
Diagnosis
Diagnosis of CIN involves:
- Pap smear tests: Screening for abnormal cells in the cervix.
- HPV testing: Identifying high-risk HPV strains.
- Colposcopy and biopsy: Further examination and tissue sampling if abnormal cells are found.
Treatment
Treatment depends on the grade of CIN:
- CIN 1: Often resolves spontaneously; regular monitoring is recommended.
- CIN 2 and CIN 3: May require more active treatment, such as cryotherapy, laser therapy, or surgical removal of the affected tissue.
Prevention and Screening
Preventive measures include HPV vaccination and regular cervical screening (Pap tests and HPV testing) to detect changes early. These strategies significantly reduce the incidence of cervical cancer.
See Also
References
- American Cancer Society. (2021). Cervical Cancer, HPV, and Cervical Dysplasia.
- World Health Organization. (2020). Human papillomavirus (HPV) and cervical cancer.
External Links
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian



